2009
DOI: 10.1016/j.ejca.2008.10.012
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a functional role for the protease-activated receptor-1 in hypoxic breast cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
11
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 30 publications
3
11
0
Order By: Relevance
“…In addition to TF, hypoxic stress has been shown to modulate PAR1 expression in tumor cell lines (32,33). Furthermore, our recent study observed increased PAR1 and PAR2 staining around necrotic areas in samples from patients with GBM (22).…”
Section: Hypoxic Induction Of Par Expression In P7 and St1 Cellsmentioning
confidence: 94%
“…In addition to TF, hypoxic stress has been shown to modulate PAR1 expression in tumor cell lines (32,33). Furthermore, our recent study observed increased PAR1 and PAR2 staining around necrotic areas in samples from patients with GBM (22).…”
Section: Hypoxic Induction Of Par Expression In P7 and St1 Cellsmentioning
confidence: 94%
“…This was further validated at the protein level confirming PAR1 global downregulation in LNCaP cells treated in hypoxic conditions. However, a recent report showed that, in MDAMDB321 aggressive breast cancer cells, hypoxia (2% oxygen) enhance PAR1 expression on the basis of conventional qRT-PCR experiments using ACTB as HKG, gel analysis for transcript quantification (Naldini et al, 2009), but no reported data regarding the choice of ACTB. Nevertheless, in our hands, MCF-7 breast cancer cells appear to have the most stable HKGs in hypoxia.…”
Section: Discussionmentioning
confidence: 99%
“…In CRC, PAR 2 activation is also protective (7,24). PAR 1 activation enhances cell survival of melanoma and breast cancer cells (38,46). Both protease receptors regulate prosurvival pathways such as ERK, Akt, and NF-B, but the final cell death or survival depends on the cell type, the amplitude, and duration of agonist exposure and the biaised agonism (35,68).…”
mentioning
confidence: 99%